Abingdon Health (LON:ABDX – Get Free Report) issued its earnings results on Tuesday. The company reported GBX (0.51) earnings per share for the quarter, Digital Look Earnings reports. Abingdon Health had a negative net margin of 33.88% and a negative return on equity of 55.91%.
Abingdon Health Stock Up 0.6%
Shares of LON:ABDX traded up GBX 0.05 during trading on Thursday, reaching GBX 9.05. 571,644 shares of the company traded hands, compared to its average volume of 237,414. The firm has a fifty day simple moving average of GBX 10.70 and a 200 day simple moving average of GBX 10.53. The firm has a market cap of £22.87 million, a P/E ratio of -11.17 and a beta of 0.13. Abingdon Health has a 1-year low of GBX 5.50 and a 1-year high of GBX 13. The company has a quick ratio of 1.96, a current ratio of 1.91 and a debt-to-equity ratio of 15.05.
About Abingdon Health
Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.
Featured Articles
- Five stocks we like better than Abingdon Health
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
